SMS Pharmaceuticals Updates Investigation as Police Arrest Accused in Impersonation Share Matter

SMS Pharmaceuticals Updates Investigation as Police Arrest Accused in Impersonation Share Matter
<h1>SMS Pharmaceuticals Updates Investigation as Police Arrest Accused in Impersonation Share Matter</h1>

SMS Pharmaceuticals Limited has provided an update regarding the police complaint concerning the impersonation of shares, which was previously communicated to stakeholders. The company confirmed that developments have occurred within the ongoing investigation into the matter.

During the course of the investigation, police authorities arrested one individual alleged to be involved in the incident. This person was subsequently presented before the Honorable XII additional Chief Judicial Magistrate, Hyderabad, on July 19, 2026, for Judicial Remand.

The company stated that the matter is currently under further investigation by police authorities. SMS Pharmaceuticals Limited remains committed to safeguarding the interests of its shareholders and will continue to take all appropriate legal measures related to the case.

SMSPHARMA Stock Price Movement​

Shares of SMS Pharmaceuticals Limited slipped today, closing at ₹384.45 after shedding ₹3.75 or 0.97%. The equity traded within a daily range of ₹383.45 to ₹393.35, recording a volume of 60,828 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top